Enrolling
A prospective clinical cohort of HIV and hepatitis C virus co-infected patients
Learn MoreCompleted
A multicenter randomized, double-blind, controlled study of NGX-4010 for the treatment of painful HIV-associated neuropathy: Trial results
Learn MoreCompleted
A Phase II, prospective, open-label, pilot study of the tolerability, safety, and efficacy of Argon plasma coagulation for the treatment of anal intraepithelial neoplasia grade 2 or 3 in HIV-positive men having sex with men
Learn MoreCompleted
A randomized trial of highly active antiretroviral therapy in acute/early HIV infection
Learn MoreCompleted
Use of valproic acid to purge HIV from resting CD4+ memory cells: Trial results
Learn MoreCompleted
A Phase I/II safety and immunogencity study of a combination of whole-killed HIV-1 antigen and Amplivax, administered with or without IFA, in HIV-1 infected Participants: Trial results
Learn MoreCompleted
Trial of Citalopram for the Prevention of Depression
Learn MoreCompleted
A Comparison of Two Ways to Manage Anti-HIV Treatment
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.
